Portugal approves AstraZeneca jab for over-65s

A safer MRI contrast agent for high-resolution 3D microvascular imaging
10 March 2021
Researchers develop guidelines for reporting polygenic risk scores
10 March 2021

Portugal approves AstraZeneca jab for over-65s

Portugal, following a number of other European countries, has approved AstraZeneca’s COVID-19 vaccine for people aged 65 and over, the DGS national health authority said on Wednesday.

Comments are closed.